首页 > 专栏 > The Lancet Oncology The Lancet Oncology 共 68 条资讯 [News] UK MHRA–NICE pathway to create faster regulatory approval 2026-06-28 08:41:55 [News] Trump's 2027 budget calls for further cuts to health research 2026-06-28 08:41:55 [Articles] Estimating global cancer survival and mortality from 1990 to 2050: a simulation-based analysis of 17 cancers 2026-06-28 08:41:55 [Policy Review] International multisociety Delphi consensus for liver tumour thermal ablation: margin assessment 2026-06-28 08:41:55 [Policy Review] Clinical trial endpoints for metastases-directed therapy in oligometastatic cancer: a review and Delphi consensus on behalf of the EORTC–ESTRO OligoCare consortium 2026-06-28 08:41:55 [Comment] AKT-targeted triplet therapy in advanced breast cancer 2026-06-28 08:41:55 [Perspectives] CHEMO MAN—or how we used to remember 2026-06-28 08:41:55 [Articles] Bayesian sequential learning for prognostication in extremity soft tissue sarcoma (BayeSarc): a retrospective, multicentre cohort study 2026-06-28 08:41:55 [Articles] Estimating total and diagnosed global cancer incidence and stage distribution from 1990 to 2050: a simulation-based analysis of 17 cancers 2026-06-28 08:41:55 [Perspectives] Turning breast cancer into art with Cancer Research UK 2026-06-28 08:41:55 [Articles] Estimating the impact of scaling up workforce personnel on global cancer mortality from 2030 to 2050: a simulation-based analysis of 17 cancers and 18 personnel types 2026-06-28 08:41:55 [Articles] On-treatment serum prostate-specific antigen and overall survival in prostate cancer (STAMPEDE platform protocol): a post-hoc analysis of data from five phase 3 trials 2026-06-28 08:41:55 [Articles] CDK4/6 inhibitors plus endocrine therapy versus endocrine monotherapy in hormone receptor-positive, HER2-negative advanced breast cancer: a reconstructed individual patient data meta-analysis of phase 3 randomised controlled trials 2026-06-28 08:41:55 [Articles] Safety and antitumour activity of ipatasertib combined with endocrine therapy and a CDK4/6 inhibitor in HR+/HER2– metastatic breast cancer (TAKTIC): a single-centre, open-label, phase 1b trial 2026-06-28 08:41:55 [Articles] Lymph node surgery and CDK4/6 inhibitors in early breast cancer: a pooled analysis from five randomised trials 2026-06-28 08:41:55 [Editorial] War in the Middle East: collateral damage 2026-06-28 08:41:55 [Policy Review] International multisociety Delphi consensus for liver tumour thermal ablation: procedural and practice standards 2026-06-28 08:41:55 [Corrections] Correction to Lancet Oncol 2026; 27: 461–69 2026-06-28 08:41:55 [Comment] Beyond efficacy: CDK4/6 inhibitors in metastatic breast cancer 2026-06-28 08:41:55 [Comment] An old tool for new strategies in advanced prostate cancer 2026-06-28 08:41:55 « 上一页1234下一页 » 相关分类 The Lancet Oncology ScienceDirect Publication: The Lancet Oncology The Lancet #!/slash/note #UNTAG (B)(F)uzzing on my world (Hi)story (IN)SECURE Magazine Notification (gdb) break *0x972 - 带鱼博客 BeltfishBlog - ./kwaa.dev .NET Blog .Trash /home/rook1e 00's Adventure 0kami's Blog 0x41414141 in ?? () 0x7f Blog 0xRick Owned Root ! 0xd00's blog 1 Byte 1A23 Blog 1A23 Studio 1Link.Fun 1stwebdesigner 251 2BAB 的工程博客 2ch中文网 360 CERT 360 Netlab Blog - Network Securi